Aldeyra Therapeutics Inc
NASDAQ:ALDX

Watchlist Manager
Aldeyra Therapeutics Inc Logo
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Watchlist
Price: 4.54 USD -1.09% Market Closed
Market Cap: 273.1m USD

Relative Value

There is not enough data to reliably calculate the relative value of ALDX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALDX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
Forward
11
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-6.6
Industry
23.7
Forward
-16
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-7.2
Industry
22
vs History
vs Industry
Median 3Y
-7
Median 5Y
-7
Industry
23.8
vs History
9
vs Industry
17
Median 3Y
3.4
Median 5Y
2.8
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
Forward
8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
32
Median 3Y
-3.9
Median 5Y
-3.9
Industry
6.4
Forward
-3.6
vs History
vs Industry
31
Median 3Y
-3.9
Median 5Y
-3.9
Industry
7
Forward
-10.9
vs History
vs Industry
31
Median 3Y
-5
Median 5Y
-5
Industry
8.3
vs History
vs Industry
28
Median 3Y
-5
Median 5Y
-5
Industry
6.5
vs History
23
vs Industry
3
Median 3Y
50.5
Median 5Y
51.2
Industry
5.7

Multiples Across Competitors

ALDX Competitors Multiples
Aldeyra Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Aldeyra Therapeutics Inc
NASDAQ:ALDX
273.1m USD 0 -6.3 -4.4 -4.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 790 068.7 -160 599.2 -195 018.6 -192 793.2
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
149.5B USD 5.1 18.4 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.9 -532 -579.3 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD 5.5 17 16.2 18.3
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
46.1B EUR 15 35.3 61 62.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.4 154.9 187.9
P/E Multiple
Earnings Growth PEG
US
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Average P/E: 186.8
Negative Multiple: -6.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 599.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
9%
1.9
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.3
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.4
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Average EV/EBITDA: 39.3
Negative Multiple: -4.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 018.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
61
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
154.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Average EV/EBIT: 45.3
Negative Multiple: -4.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 793.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
62.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
187.9
N/A N/A